Niacin And Niacinamide Market Outlook 20262031: USD 1.99 Billion Opportunity As Demand For Vitamin B3 In Skincare And Nutrition Grows, Reports Mordor Intelligence

(MENAFN- GlobeNewsWire - Nasdaq) The niacin and niacinamide market are projected to grow at a CAGR of 4.55% during 2026–2031, supported by increasing demand for vitamin B3 in pharmaceutical formulations, food and feed fortification, dietary supplements, and skincare products. Asia-Pacific leads the market, while North America is expected to register the fastest growth.

Hyderabad, India, Oct. 22, 2026 (GLOBE NEWSWIRE) -- According to the latest report by Mordor Intelligence, the niacin and niacinamide market size is estimated to increase from USD 1.59 billion in 2026 to USD 1.99 billion by 2031, registering a CAGR of 4.55% during the forecast period from 2026 to 2031. Market growth is supported by expanding applications of vitamin B3 across pharmaceuticals, human nutrition, animal nutrition, food and beverages, and cosmetics and personal care. Rising demand for specialized ingredient grades, preventive healthcare products, and skincare formulations is further shaping the market.

The niacin and niacinamide market are evolving as manufacturers address demand from both established nutritional applications and higher-value specialty products. Niacin, also known as nicotinic acid, and niacinamide, also called nicotinamide, are forms of vitamin B3 used in nutritional formulations, pharmaceuticals, and personal care products. Food fortification programs and animal nutrition requirements continue to support demand for established applications, while niacinamide is gaining traction in skincare formulations designed to support the skin barrier, manage uneven skin tone, and improve overall skin appearance.

Niacin and Niacinamide Market Share by Region

Asia-Pacific remained the leading regional market for niacin and niacinamide in 2025, supported by established manufacturing capacity, pharmaceutical production, animal nutrition demand, and expanding personal care industries. China plays an important role in ingredient manufacturing, while India contributes through pharmaceutical and nutraceutical production. Demand from Japan and South Korea's cosmetics industries further supports regional consumption, particularly for high-quality niacinamide used in specialized skincare formulations.

North America is expected to be the fastest-growing regional market, registering a CAGR of 7.25% through 2031. Growth is supported by demand for dietary supplements, pharmaceutical-grade vitamin B3, and science-led skincare products. Increasing consumer interest in preventive healthcare and premium personal care formulations is encouraging manufacturers to expand product portfolios and secure consistent supplies of high-quality ingredients.

Europe represents an established market, supported by pharmaceutical manufacturing, food and animal feed applications, and demand for specialty cosmetic ingredients. Regulatory compliance, ingredient traceability, and growing interest in sustainable manufacturing practices are influencing supplier selection and encouraging investment in differentiated ingredient grades.

“Demand for niacin and niacinamide is expanding across pharmaceutical, nutritional, and personal care applications, supported by growing interest in preventive health and multifunctional skincare ingredients. Continued product innovation and evolving formulation requirements are creating opportunities for manufacturers to address diverse end-use needs,” says Soumya Goud, Senior Research Manager, Mordor Intelligence.

Niacin and Niacinamide Market Trends & Forecast

Growing Demand for Niacinamide in Cosmetics and Personal Care

Niacinamide is gaining importance in skincare formulations because of its versatility across products targeting skin-barrier support, uneven pigmentation, sebum regulation, and visible signs of aging. Its incorporation into serums, moisturizers, and other everyday skincare products is expanding opportunities for ingredient manufacturers. This growth reflects increasing demand for multifunctional cosmetic ingredients and the expansion of skincare products across mass-market and premium categories.

Expanding Applications in Pharmaceuticals and Nutrition

Pharmaceuticals remain an important application for niacin and niacinamide, supporting the treatment of nutritional deficiencies and the development of pharmaceutical and nutritional formulations. Demand from human nutrition, food and beverage fortification, and animal feed applications also supports overall consumption. Manufacturers serving these applications must meet relevant quality specifications and supply requirements, creating opportunities for established suppliers with consistent production capabilities.

Increasing Interest in Bio-Based Production and Specialized Ingredients

Ingredient buyers are increasingly assessing production methods, traceability, and quality documentation alongside price and availability. Synthetic ingredients continue to dominate supply because of established production processes and manufacturing scale. However, natural and bio-based materials are expected to grow through 2031, reflecting interest in alternative production approaches. This development is creating opportunities for suppliers to serve customers seeking differentiated ingredients for cosmetics, nutrition, and other specialized applications.

Niacin and Niacinamide Market Segmentation Overview

The niacin and niacinamide market are segmented by product type, source, form, application, distribution channel, and geography.

By Product Type

• Niacin
  

• Niacinamide

By Source

• Synthetic

• Natural and Bio-Based

By Form

• Powder

• Granular

• Liquid

By Application

• Pharmaceuticals

• Human Nutrition

• Animal Nutrition

• Food and Beverages

• Cosmetics and Personal Care

By Distribution Channel

• Direct Sales and Contract Supply

• Distributors and Wholesalers

• Hospital Pharmacies

• Drug Stores and Retail Pharmacies

• Online Retail and E-commerce
  

By Geography

• North America

• United States

• Canada

• Mexico

• Europe

• Germany

• United Kingdom

• France

• Italy

• Spain

• Rest of Europe

• Asia-Pacific

• China

• Japan

• India

• Australia

• South Korea

• Rest of Asia-Pacific

• Middle East and Africa
  

• GCC

• South Africa

• Rest of Middle East and Africa

• South America

• Brazil

• Argentina

• Rest of South America

The market's segmentation reflects the different requirements of nutritional, pharmaceutical, and personal care applications. Niacinamide held the largest share by product type in 2025 and is projected to register the fastest growth among product types through 2031. Synthetic ingredients continue to lead by source, while bio-based materials are gaining attention. By application, pharmaceuticals represent the largest segment, whereas cosmetics and personal care are expected to expand more rapidly. These differences highlight the importance of product quality, formulation requirements, and end-use demand in shaping future market opportunities.

For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report:

Niacin and Niacinamide Market Competitive Outlook

The niacin and niacinamide market features established chemical manufacturers, pharmaceutical ingredient suppliers, and specialty ingredient companies serving nutritional, pharmaceutical, animal feed, and personal care applications. Competition is shaped by production capacity, ingredient purity, regulatory compliance, pricing, supply reliability, and the ability to meet application-specific customer requirements.

Niacin and Niacinamide Industry Leaders

• BASF SE

• dsm-firmenich AG

• Lonza Group AG

• Jubilant Pharmova Limited

• Vanetta Food Ingredients

Other companies covered in the competitive landscape include Brother Enterprises Holding Co., Ltd., Evonik Industries AG, Hubei Guangji Pharmaceutical Co., Ltd., Kyowa Hakko Bio Co., Ltd., Lasons India Pvt. Ltd., Merck KGaA, Vertellus Holdings LLC, and Zhejiang NHU Co., Ltd.

Check Out Related Reports Published by Mordor Intelligence

Nutrition Therapy Market - The nutrition therapy market is expected to grow from USD 59.29 billion in 2026 to USD 80.74 billion by 2031, registering a CAGR of 6.40%, supported by rising demand for specialized nutritional support, increasing prevalence of chronic diseases, and growing awareness of nutrition's role in disease management and recovery.

Meglitinide Market - The meglitinide market is projected to expand from USD 4.55 billion in 2026 to USD 5.07 billion by 2031, at a CAGR of 2.21%, driven by the ongoing need for oral medications to manage type 2 diabetes, increasing diabetes prevalence, and continued demand for treatments that help regulate blood glucose levels.

Dermatological Therapeutics Market - The dermatological therapeutics market is expected to grow from USD 54.06 billion in 2026 to USD 83.59 billion by 2031, registering a CAGR of 9.12%, supported by the rising prevalence of skin disorders, growing demand for advanced dermatological treatments, and increasing focus on skin health and personalized care.

About Mordor Intelligence

Mordor Intelligence is a global market intelligence firm, founded in 2014, helping businesses make informed decisions through data-driven insights, industry expertise, and advanced analytics. With 550+ domain experts and on-ground specialists across 150+ countries, the company delivers comprehensive intelligence across aerospace & defense, agriculture, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, and logistics.

Its offerings include syndicated industry reports Synapse, Data Center Intelligence, and Robotics Intelligence. Mordor Intelligence is ISO 9001:2015 and ISO/IEC 27001:2022 certified, a member of ESOMAR and the Market Research Society of India, and a four-time Great Place to Work® honoree. Learn more at mordorintelligence.com

CONTACT: For any inquiries or to access the full report, please contact:...

MENAFN22102026004107003653ID1111850292